 |
|
Discovery could lead to new types of Alzheimer's drugs
July 12, 2005(Santa Barbara, Calif.) -- A ground-breaking new research approach to understanding the cellular processes of Alzheimer's and other degenerative diseases has revealed a promising pathway to the development of new types of drugs for these diseases.
The discovery, made in the laboratory of Ratnesh Lal, research scientist in the Neuroscience Research Institute (NRI) at the University of California, Santa Barbara, is published in this week's online issue of the Proceedings of the National Academy of Sciences (PNAS).
The research describes a new way of understanding the degeneration of brain cells in patients with Alzheimer's, Huntington's, and Parkinson's diseases, as well as other degenerative diseases. Misfolded proteins in the cell membrane, and subsequent changes in the electrical properties of cells, provide the explanation for the cell degeneration. Specific three-dimensional structures of misfolded proteins are embedded in the cell membrane.
"It has long been thought that amyloid plaque, which has been studied for 30 years, was the cause of Alzheimer's disease," said Lal. "Plaque isn't the cause." He explained that the fibers of plaque are too large to directly affect small cells.
The answers may come from small globs of misshapen, misfolded proteins that make well-defined holes in cell membranes and disrupt their electrical activity, according to the study.
Amyloid protein is a sticky, globular substance created when normal cellular proteins become twisted and contorted into abnormal shapes. While amyloid formation has been associated with diseases like Alzheimer's, Parkinson's, and Huntington's, scientists have puzzled over whether and how it actually kills cells and causes disease. To gain insight into this mysterious process, Lal and his research team examined the three-dimensional structure of several different proteins associated with these diseases. The researchers observed that all of the proteins folded into structures resembling ion channels, or pores within cell membranes. These pores control the electrical properties of the cell by regulating the flow of charged particles (ions) such as calcium.
When embedded into artificial membranes, the misfolded proteins were able to produce electrical currents, confirming their similarity to ion channels. Since abnormal ion balance is known to disrupt cell function and cause degeneration, these results provide proof of a possible mechanism by which amyloid formation may lead to the cellular destruction seen in these neurodegenerative diseases.
"These ion channels could serve as a model system for designing preventive and therapeutic drugs," said Lal. "You don't need large aggregates of these amyloid proteins, the plaque, to have this disruption. Rather, small aggregates, when in contact with membrane, form ion channels and allow passage of ion current. By controlling activity and designing specific drugs to regulate these channels, we might be able to prevent and/or treat various diseases related to the amyloids."
These findings provide a major piece of the puzzle about the underlying protein misfolding associated with these degenerative diseases. Besides the diseases already mentioned, other degenerative diseases that also result from misfolded proteins include cystic fibrosis, type II diabetes, cerebrovascular dementia, arthritis, tuberculosis, as well as British and Danish famial dementias.
The researchers used atomic force microscopy (AFM) to view the ion channels. By using the AFM they were able to view these "bio-nano" molecules. The AFM allows for a look at these very small channels, which would be very difficult if not impossible to see in their native, cell-like environment with electron microscopy.
In addition to Lal, the authors of this path-breaking paper are: Arjan Quist and Ivo Doudevski of the NRI at UCSB; Han Lin of the University of Pittsburgh; Rushana Azimova and Bruce Kagan of the University of California, Los Angeles; and Douglas Ng, Blas Frangione, and Jorge Ghiso of New York University.
University of California-Santa Barbara
"It has long been thought that amyloid plaque, which has been studied for 30 years, was the cause of Alzheimer's disease," said Lal. "Plaque isn't the cause." He explained that the fibers of plaque are too large to directly affect small cells.
The answers may come from small globs of misshapen, misfolded proteins that make well-defined holes in cell membranes and disrupt their electrical activity, according to the study.
Amyloid protein is a sticky, globular substance created when normal cellular proteins become twisted and contorted into abnormal shapes. While amyloid formation has been associated with diseases like Alzheimer's, Parkinson's, and Huntington's, scientists have puzzled over whether and how it actually kills cells and causes disease. To gain insight into this mysterious process, Lal and his research team examined the three-dimensional structure of several different proteins associated with these diseases. The researchers observed that all of the proteins folded into structures resembling ion channels, or pores within cell membranes. These pores control the electrical properties of the cell by regulating the flow of charged particles (ions) such as calcium.
When embedded into artificial membranes, the misfolded proteins were able to produce electrical currents, confirming their similarity to ion channels. Since abnormal ion balance is known to disrupt cell function and cause degeneration, these results provide proof of a possible mechanism by which amyloid formation may lead to the cellular destruction seen in these neurodegenerative diseases.
"These ion channels could serve as a model system for designing preventive and therapeutic drugs," said Lal. "You don't need large aggregates of these amyloid proteins, the plaque, to have this disruption. Rather, small aggregates, when in contact with membrane, form ion channels and allow passage of ion current. By controlling activity and designing specific drugs to regulate these channels, we might be able to prevent and/or treat various diseases related to the amyloids."
These findings provide a major piece of the puzzle about the underlying protein misfolding associated with these degenerative diseases. Besides the diseases already mentioned, other degenerative diseases that also result from misfolded proteins include cystic fibrosis, type II diabetes, cerebrovascular dementia, arthritis, tuberculosis, as well as British and Danish famial dementias.
The researchers used atomic force microscopy (AFM) to view the ion channels. By using the AFM they were able to view these "bio-nano" molecules. The AFM allows for a look at these very small channels, which would be very difficult if not impossible to see in their native, cell-like environment with electron microscopy.
In addition to Lal, the authors of this path-breaking paper are: Arjan Quist and Ivo Doudevski of the NRI at UCSB; Han Lin of the University of Pittsburgh; Rushana Azimova and Bruce Kagan of the University of California, Los Angeles; and Douglas Ng, Blas Frangione, and Jorge Ghiso of New York University.
University of California-Santa Barbara
Alzheimers Current Events and Alzheimers News RSSFamilies shed light on likely causative gene for Alzheimer's
The genetic profile of two large Georgia families with high rates of late-onset Alzheimer's disease points to a gene that may cause the disease, researchers say.
Scientists explore consciousness
An international team of scientists led by a University of Leicester researcher has carried out a scientific study into the realm of consciousness.
High-Trauma Fractures in Older Men and Women Linked to Osteoporosis
Researchers at the California Pacific Medical Center (CPMC) Research Institute are challenging a widely held belief that fractures resulting from major trauma, such as automobile accidents, are not related to osteoporosis, the common disease that makes bones weak and prone to fracture.
What makes Mars magnetic?
Earth's surface is a very active place; its plates are forever jiggling around, rearranging themselves into new configurations. Continents collide and mountains arise, oceans slide beneath continents and volcanoes spew.
Cold sore virus might play role in Alzheimer's disease
A gene known to be a major risk factor for Alzheimer's disease puts out the welcome mat for the virus that causes cold sores, allowing the virus to be more active in the brain compared to other forms of the gene.
Study offers window into human behavior, brain disease
UCSF scientists have identified a cell population that is a primary target of the degenerative brain disease known as frontotemporal dementia, which is as common as Alzheimer's disease in patients who develop dementia before age 65.
New imaging compound might 'see' Alzheimer's earlier
A new imaging molecule that can detect and map plaques and tangles in the brains of people with Alzheimer's disease could eventually lead to earlier diagnosis of the devastating disease, researchers at the University of California, Los Angeles report in the Dec. 21, 2006, issue of the New England Journal of Medicine.
Testosterone therapy may prevent Alzheimer's disease
Researchers at the University of Southern California have discovered a direct link between loss of testosterone and the development of an Alzheimer's-like disease in mice. They also discovered that testosterone treatment slows progression of the disease.
Androgen therapy may slow progress of Alzheimer's disease
Experiments on mouse models of Alzheimer's disease (AD) suggest that treatment with male sex hormones might slow its progression.
Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease
Scientists collaborating at Cornell University in Ithaca and Weill Cornell Medical College in New York City have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical "fingerprint," which doctors might use someday to identify patients living with Alzheimer's disease.
More Alzheimers Current Events and Alzheimers News Articles
 | The Anti-Alzheimer's Prescription: The Science-Proven Plan to Start at Any Age by Vincent Fortanasce From a world-renowned neurologist: the first book to feature a scientifically substantiated program for the only treatment for Alzheimer’s: prevention. Alzheimer’s is pandemic among older adults worldwide, and as baby boomers age it promises to be the Great American Epidemic of the twenty-first century. Unlike other books in the category, which focus primarily on caring for an Alzheimer’s... |
 | Learning to Speak Alzheimer's: A Groundbreaking Approach for Everyone Dealing with the Disease by Joanne Koenig Coste More than four million Americans suffer from Alzheimer's, and as many as twenty million have close relatives or friends with the disease. Revolutionizing the way we perceive and live with Alzheimer's, Joanne Koenig Coste offers a practical approach to the emotional well-being of both patients and caregivers that emphasizes relating to patients in their own reality. Her accessible and... |
 | The Alzheimer's Action Plan: The Experts' Guide to the Best Diagnosis and Treatment for Memory Problems by P. Murali Doraiswamy, Lisa P. Gwyther, Tina Adler Is it really Alzheimer’s? How to find out and intervene early to maintain the highest quality of life“Most of us will either get Alzheimer’s or care for a loved one who has. This action plan can empower you to make a difference.”---Mehmet C. Oz, M.D.What would you do if your mother was having memory problems? Alzheimer’s is a disease affecting more than five million Americans, with a... |
 | What If It's Not Alzheimer's?: A Caregiver's Guide to Dementia (Updated & Revised) Includes Vital Information on Frontotemporal Dementia (FTD) Foreword by John Q. Trojanowski, MD, PhD, Director, Alzheimer's Disease Center, University of Pennsylvania Hospital Although the public most often associates dementia with Alzheimer's disease, the medical profession now distinguishes various types of "other" dementias. This book is the first comprehensive guide dealing with ... |
 | A Caregiver's Guide to Alzheimer's Disease: 300 Tips for Making Life Easier Written for patients, their families, and caregivers, the practical information here will help readers understand what is physically happening to the brain so they can empower their own special skills and talents throughout the disease process. The book is divided into three sections that correspond to the progression of Alzheimer’s, and the unique challenges encountered at each stage. ... |
 | Alzheimer's from the Inside Out by Richard Taylor Receiving a diagnosis of Alzheimer’s disease profoundly alters lives and creates endless uncertainty about the future. How does a person cope with such a life-changing discovery? What are the hopes and fears of someone living with this disease? How does he want to be treated? How does he feel as the disease alters his brain, his relationships, and ultimately himself? Richard Taylor provides... |
 | Talking to Alzheimer's: Simple Ways to Connect When You Visit with a Family Member or Friend by Claudia J. Strauss Few books manage to balance practical suggestions and loving sympathy as well as Talking to Alzheimer's, a concise and comprehensive guide to communication with both paid caregivers and their patients. While the title suggests focus on a specific disease, the recommendations are appropriate for any family struggling with serious communication issues, whether those issues are the result of stroke,... |
 | Inside Alzheimer's: How to Hear and Honor Connections with a Person who has Dementia by Nancy Pearce We have long underestimated the person who has dementia. Each one's ability to reach out in familiar ways certainly diminishes yet he or she is always able to experience the deep benefits that come from being in vital relationship with others. Inside Alzheimer's tells how dozens of persons with dementia and their sharing of wisdom, humor and life's teachings led Ms. Pearce to the six basic... |
 | Alzheimer's Early Stages: First Steps for Family, Friends and Caregivers by Daniel Kuhn This edition includes the latest information on Alzheimer’s risk factors, treatments, and prevention, as well as a new chapter, "Voices of Experience," composed of reflections by family members. It also provides information about new drugs approved since 1999 and the federal government’s decision to cover counseling and other health-related services through... |
 | The Alzheimer's Answer: Reduce Your Risk and Keep Your Brain Healthy by Marwan Sabbagh Drawing on the most up-to-date information available on the disease as well as experiences from his clinical practice, Dr. Sabbagh, a leading expert in Alzheimer's research, translates the current ideas driving Alzheimer's treatment into practical information you can use to determine your risk and develop a prevention strategy. You’ll find tools for assessing your personal Alzheimer's risk and... |
| © 2008 BrightSurf.com |